Should people with HIV infection, pneumocystis pneumonia, and hypoxaemia receive corticosteroids? Evidence Update, HIV/AIDS Series, March 2007

From:
Department for International Development
Published
1 January 2007
Document Type:
Briefing
Theme:
Health

Abstract

Each Evidence Update is a 2-page summary of a Cochrane Review of healthcare interventions relevant to people in low-income and middle-income countries.

This Evidence Update is adding corticosteroids to usual treatment reduces mortality and need for mechanical ventilation in people with HIV infection, pneumocystis pneumonia, and hypoxaemia.

Adding corticosteroids to usual treatment reduces mortality and need for mechanical ventilation in people with HIV infection, pneumocystis pneumonia, and hypoxaemia.

Citation

Anon. Should people with HIV infection, pneumocystis pneumonia,and hypoxaemia receive corticosteroids? Evidence Update, HIV/AIDS Series, March 2007. Effective Health Care Alliance Programme Consortium, Liverpool School of Tropical Medicine, Liverpool, UK (2007)

Should people with HIV infection, pneumocystis pneumonia, and hypoxaemia receive corticosteroids? Evidence Update, HIV/AIDS Series, March 2007

Published 1 January 2007
Contents